Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05729061 · ClinicalTrials.gov registry record · NA

Analysis of Human Movement With Assistive Devices

A NA study of Movement Disorders and Limb Loss, sponsored by Orthocare Innovations.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05729061: Recruiting NA study of Movement Disorders and Limb Loss, sponsored by Orthocare Innovations.

NCT05729061 is a NA study of Movement Disorders and Limb Loss that is actively recruiting participants, run by Orthocare Innovations. The registered enrollment target is 100 participants, below the 1,064-participant average among 26 other Movement Disorders trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05729061, a NA study of Movement Disorders and Limb Loss, is actively recruiting participants, sponsored by Orthocare Innovations.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to evaluate how people move about in different settings with different assistive devices or components, and to understand how people interact with different assistive technologies. Individuals that have limb weakness, limb paralysis, limb loss, and movement disorders are often provided assistive devices such as prostheses and orthoses to assist with mobility or use assistive technologies for purposes such as to regain muscle strength or retrain movements. It is important to understand the impact of these different assistive technologies on human movement for technology improvement and in preparation for commercialization. Because this research focuses on evaluating how different people move about in different settings with different assistive devices/components, there are different activities that may take place. These activities have been classified as (1) Movement Analysis in the Laboratory, (2) Movement Analysis Outside the Laboratory, (3) Usability Testing, and (4) Focus Groups. Each participant may or may not complete the same activities as the other participants. Each participant may or may not complete all of the activities. Participants may complete the activities more than once.

Primary Outcome

Walking speed determined over 8 meters of walking

Interventions

  • DEVICE Assist-Knee
  • DEVICE Prosthetic Knee
  • DEVICE Prosthetic Ankle
  • DEVICE Prosthetic Foot
  • DEVICE Ankle-Foot Orthosis

Study Locations (1)

Washington

  • Orthocare Innovations, LLC - Edmonds

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-11-28
Est. Completion 2024-11-28
Phase NA
Orthocare Innovations

4 total trials

What NCT05729061 shows while recruiting

NCT05729061 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,064-participant average among 26 other Movement Disorders trials with a reported enrollment target (91% lower).

The record links to 4 conditions, with Movement Disorders appearing as the primary indexed condition, and to 5 interventions - of which Assist-Knee is the first listed.

NCT05729061 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT05729061 about?

NCT05729061 is a clinical study titled "Analysis of Human Movement With Assistive Devices". The purpose of this research is to evaluate how people move about in different settings with different assistive devices or components, and to understand how people interact with different assistive technologies. Individuals that have limb weakness, limb paralysis, limb loss, and movement disorders ...

What is the current status of trial NCT05729061?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-11-28. Estimated completion is 2024-11-28.

What conditions does trial NCT05729061 study?

This clinical trial studies the following conditions: Movement Disorders, Limb Loss, Limb Weakness, Limb Paralysis.

What interventions are being tested in trial NCT05729061?

The interventions under investigation include: Assist-Knee (DEVICE), Prosthetic Knee (DEVICE), Prosthetic Ankle (DEVICE), Prosthetic Foot (DEVICE), Ankle-Foot Orthosis (DEVICE).

Who is sponsoring clinical trial NCT05729061?

This trial is sponsored by Orthocare Innovations, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05729061 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Movement Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05729061's enrollment target sits among peer trials

100 13th of 26 higher than 11 of 26 other Movement Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Movement Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05729061, the US trial registry maintained by the National Library of Medicine. NCT05729061 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.